-
1
-
-
0035157377
-
The Schnitzler syndrome. Four new cases and review of the literature
-
D.Lipsker, Y.Veran, F.Grunenberger, The Schnitzler syndrome. Four new cases and review of the literature. Medicine 2001;80:37–44
-
(2001)
Medicine
, vol.80
, pp. 37-44
-
-
Lipsker, D.1
Veran, Y.2
Grunenberger, F.3
-
2
-
-
84876685876
-
Schnitzler’s syndrome: diagnosis, treatment, and follow-up
-
A.Simon, B.Asli, M.Braun-Falco, Schnitzler’s syndrome:diagnosis, treatment, and follow-up. Allergy 2013;68:562–8
-
(2013)
Allergy
, vol.68
, pp. 562-568
-
-
Simon, A.1
Asli, B.2
Braun-Falco, M.3
-
3
-
-
36348963104
-
Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment
-
H.D.de Koning, E.J.Bodar, J.W.van der Meer, Schnitzler syndrome:beyond the case reports:review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum. 2007;37:137–48
-
(2007)
Semin Arthritis Rheum
, vol.37
, pp. 137-148
-
-
de Koning, H.D.1
Bodar, E.J.2
van der Meer, J.W.3
-
4
-
-
84908146365
-
Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler’s syndrome: a French multicenter study
-
A.Néel, B.Henry, S.Barbarot, Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler’s syndrome:a French multicenter study. Autoimmun Rev. 2014;13:1035–41
-
(2014)
Autoimmun Rev
, vol.13
, pp. 1035-1041
-
-
Néel, A.1
Henry, B.2
Barbarot, S.3
-
5
-
-
84883790466
-
Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler’s syndrome
-
H.D.de Koning, J.Schalkwijk, J.van der Ven-Jongekrijg, Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler’s syndrome. Ann Rheum Dis. 2013;72:1634–8
-
(2013)
Ann Rheum Dis
, vol.72
, pp. 1634-1638
-
-
de Koning, H.D.1
Schalkwijk, J.2
van der Ven-Jongekrijg, J.3
-
6
-
-
84862010053
-
Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study
-
K.Krause, K.Weller, R.Stefaniak, Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome:an open-label study. Allergy 2012;67:943–50
-
(2012)
Allergy
, vol.67
, pp. 943-950
-
-
Krause, K.1
Weller, K.2
Stefaniak, R.3
-
7
-
-
22244467732
-
Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al
-
V.M.Martinez-Taboada, A.Fontalba, R.Blanco, J.L.Fernández-Luna Successful treatment of refractory Schnitzler syndrome with anakinra:comment on the article by Hawkins et al. Arthritis Rheum. 2005;52:2226–7
-
(2005)
Arthritis Rheum
, vol.52
, pp. 2226-2227
-
-
Martinez-Taboada, V.M.1
Fontalba, A.2
Blanco, R.3
Fernández-Luna, J.L.4
-
8
-
-
79952266366
-
Treatment of Schnitzler’s syndrome with anakinra: report of three cases and review of the literature
-
J.T.Gran, Ø.Midtvedt, S.Haug, P.Aukrust Treatment of Schnitzler’s syndrome with anakinra:report of three cases and review of the literature. Scand J Rheumatol. 2011;40:74–9
-
(2011)
Scand J Rheumatol
, vol.40
, pp. 74-79
-
-
Gran, J.T.1
Midtvedt, Ø.2
Haug, S.3
Aukrust, P.4
-
9
-
-
78649781218
-
The Schnitzler syndrome
-
D.Lipsker The Schnitzler syndrome. Orphanet J Rare Dis. 2010;5:38. doi:10.1186/1750-1172-5-38
-
(2010)
Orphanet J Rare Dis
, vol.5
, pp. 38
-
-
Lipsker, D.1
-
10
-
-
84864545087
-
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
-
C.A.Dinarello, A.Simon, J.W.van der Meer Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11:633–52
-
(2012)
Nat Rev Drug Discov
, vol.11
, pp. 633-652
-
-
Dinarello, C.A.1
Simon, A.2
van der Meer, J.W.3
-
11
-
-
34447267950
-
Schnitzler syndrome: treatment failure to rituximab but response to anakinra
-
E.Eiling, M.Möller, I.Kreiselmaier, Schnitzler syndrome:treatment failure to rituximab but response to anakinra. J Am Acad Dermatol. 2007;57:361–4
-
(2007)
J Am Acad Dermatol
, vol.57
, pp. 361-364
-
-
Eiling, E.1
Möller, M.2
Kreiselmaier, I.3
-
12
-
-
84863430275
-
Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome
-
T.Volz, F.Wölbing, J.Fischer, Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome. Acta Derm Venereol. 2012;92:393–4
-
(2012)
Acta Derm Venereol
, vol.92
, pp. 393-394
-
-
Volz, T.1
Wölbing, F.2
Fischer, J.3
-
13
-
-
18644374105
-
Blocking IL-1 in systemic inflammation
-
C.A.Dinarello Blocking IL-1 in systemic inflammation. J Exp Med. 2005;201:1355–9
-
(2005)
J Exp Med
, vol.201
, pp. 1355-1359
-
-
Dinarello, C.A.1
-
15
-
-
38149024742
-
IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission
-
J.G.Ryan, H.D.de Koning, L.A.Beck, IL-1 blockade in Schnitzler syndrome:ex vivo findings correlate with clinical remission. J Allergy Clin Immunol. 2008;121:260–2
-
(2008)
J Allergy Clin Immunol
, vol.121
, pp. 260-262
-
-
Ryan, J.G.1
de Koning, H.D.2
Beck, L.A.3
-
16
-
-
84978022581
-
Schnitzler’s syndrome: lessons from 281 cases
-
H.D.de Koning Schnitzler’s syndrome:lessons from 281 cases. Clin Transl Allergy. 2014;4:41
-
(2014)
Clin Transl Allergy
, vol.4
, pp. 41
-
-
de Koning, H.D.1
-
17
-
-
79551572464
-
[A woman with recurrent urticaria, joint pain and fever]
-
J.T.Gran, Ø.Midtvedt, S.Haug [A woman with recurrent urticaria, joint pain and fever]. Tidsskr nor Laegeforen. 2011;131:135–6
-
(2011)
Tidsskr nor Laegeforen
, vol.131
, pp. 135-136
-
-
Gran, J.T.1
Midtvedt, Ø.2
Haug, S.3
|